Validating Benefits News Today

Long speculated to slow or even reverse aging in off-label use, the generic drugs metformin and rapamycin are getting formal clinical trials this year.

A study found healthy people taking organ-transplant drug rapamycin off-label showed signs of improved health, and even COVID resistance.

It has been earmarked as a potential longevity drug in recent years after promising studies in mice showed it could increase overall lifespan.

Columbia University is launching a new study to determine if a common cancer drug can help slow down ageing in ovaries and delay menopause.